Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation-Reference-Cited by-同舟云学术

Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation

Published:2016-11-24 Issue:52 Volume:7 Page:87161-87179
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chien Yueh¹²,Chien Chian-Shiu¹²,Chiang Huai-Chih¹²,Huang Wei-Lin¹³,Chou Shih-Jie¹²,Chang Wei-Chao⁴,Chang Yuh-Lih⁵²,Leu Hsin-Bang⁶⁷,Chen Kuan-Hsuan⁵⁷,Wang Kang-Ling⁶⁷,Lai Ying-Hsiu⁷,Liu Yung-Yang¹⁷,Lu Kai-Hsi⁸,Li Hsin-Yang¹³,Sung Yen-Jen³,Jong Yuh-Jyh⁹,Chen Yann-Jang¹⁰,Chen Chung-Hsuan¹¹¹²,Yu Wen-Chung⁶¹³

Affiliation:

1. Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan

2. Institute of Pharmacology, Taipei, Taiwan

3. Institute of Anatomy and Cell Biology, Taipei, Taiwan

4. Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University and Department of Biotechnology, Asia University, Taichung, Taiwan

5. Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan

6. Division of Cardiology & Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

7. Institute of Clinical Medicine, Taipei, Taiwan

8. Department of Medical Research, Cheng-Hsin Hospital, Taipei, Taiwan

9. College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan

10. Department of Life Sciences and Institute of Genome Sciences, Taipei, Taiwan

11. Genomics Research Center, Academia Sinica, Taipei, Taiwan

12. Department of Chemistry, National Taiwan University, Taipei, Taiwan

13. Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study;ESC Heart Failure;2024-09-03

2. Inflammatory cytokine expression in Fabry disease: impact of disease phenotype and alterations under enzyme replacement therapy;Frontiers in Immunology;2024-08-21

3. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?;Rare Disease and Orphan Drugs Journal;2024-04-25

4. Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells;Stem Cells and Development;2022-05-01

5. Pericardial effusion in the course of Fabry disease cardiomyopathy: a case report;European Heart Journal - Case Reports;2021-10-01